These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25020072)

  • 1. Atomoxetine-induced mania with auditory hallucination in an 8-year-old boy with attention-deficit/hyperactivity disorder and tic disorder.
    Liu CC; Lan CC; Chen YS
    J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):466-7. PubMed ID: 25020072
    [No Abstract]   [Full Text] [Related]  

  • 2. Atomoxetine-induced mania-like symptoms in an adolescent patient.
    Bahali K; Uneri OS; Ipek H
    Actas Esp Psiquiatr; 2013; 41(2):137-8. PubMed ID: 23592075
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment of attention deficit hyperactivity disorder with comorbid tic hyperkinesis].
    Chutko LS; Surushkina SIu; Nikishena IS; Iakovenko EA; Lapshina OV; Anisimova TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(2):66-8. PubMed ID: 18646384
    [No Abstract]   [Full Text] [Related]  

  • 4. Atomoxetine-induced hypomania-like symptoms in a preadolescent patient.
    Guney E; Uneri OS
    J Child Adolesc Psychopharmacol; 2014 Nov; 24(9):530-1. PubMed ID: 24494808
    [No Abstract]   [Full Text] [Related]  

  • 5. Atomoxetine hydrochloride-associated transient psychosis in an adolescent with attention-deficit/hyperactivity disorder and mild mental retardation.
    Tang CS; Chou WJ; Cheng AT
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):319-20. PubMed ID: 19519271
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistent camptocormia associated with atomoxetine in a child with attention-deficit/hyperactivity disorder.
    Bhattacharya A; Praharaj SK; Sinha VK
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):596-7. PubMed ID: 25469421
    [No Abstract]   [Full Text] [Related]  

  • 7. Atomoxetine-induced vocal tics in a patient with schizophrenia.
    Raveendranathan D; Rao MG; Varambally S; Venkatasubramanian G; Gangadhar BN
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E45-6. PubMed ID: 23224483
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.
    ; Bangs ME; Emslie GJ; Spencer TJ; Ramsey JL; Carlson C; Bartky EJ; Busner J; Duesenberg DA; Harshawat P; Kaplan SL; Quintana H; Allen AJ; Sumner CR
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):407-20. PubMed ID: 17822337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of severe akathisia with atomoxetine.
    Baweja R; Petrovic-Dovat L
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):426-7. PubMed ID: 23952192
    [No Abstract]   [Full Text] [Related]  

  • 10. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD.
    Yu SH; Chou JY; Robson D; Chen VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1355-6. PubMed ID: 20619310
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased blood pressure and atomoxetine.
    Dworkin N
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):510. PubMed ID: 15908831
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute suicidality after commencing atomoxetine.
    Paxton GA; Cranswick NE
    J Paediatr Child Health; 2008 Oct; 44(10):596-8. PubMed ID: 19012633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomoxetine-induced mydriasis.
    Alhatem FJ; Decker DH
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):539-41. PubMed ID: 18928421
    [No Abstract]   [Full Text] [Related]  

  • 15. Atomoxetine-induced hyponatremia.
    Singh T
    Aust N Z J Psychiatry; 2007 May; 41(5):458. PubMed ID: 17464740
    [No Abstract]   [Full Text] [Related]  

  • 16. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
    Párraga HC; Párraga MI; Harris DK
    Int J Psychiatry Med; 2007; 37(4):415-24. PubMed ID: 18441629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorder.
    Takahashi M; Takita Y; Goto T; Ichikawa H; Saito K; Matsumoto H; Tanaka Y
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):55-63. PubMed ID: 21265936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does atomoxetine increase the risk of aggression and hostility in children with attention deficit hyperactivity disorder?
    Banerjee S; Ayyash HF
    Arch Dis Child Educ Pract Ed; 2008 Aug; 93(4):131-2. PubMed ID: 18644903
    [No Abstract]   [Full Text] [Related]  

  • 19. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of tics in a thirteen-year-old male following atomoxetine use.
    Sears J; Patel NC
    CNS Spectr; 2008 Apr; 13(4):301-3. PubMed ID: 18408649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.